Patents-Review.com
ClassID:

93226 āŽ˜

C07C275/50 - CPC Classification

Classification description:

Derivatives of urea, i.e. compounds containing any of the groups , the nitrogen atoms not being part of nitro or nitroso groups containing any of the groups , X being a hetero atom, Y being any atom, e.g. acylureas; Y being a hydrogen or a carbon atom Y being a hydrogen or an acyclic carbon atom

Recent Application in this class:
#1
20260098008
2026-04-09

COVALENT, CHEMOGENETIC ACTIVATORS FOR K2P POTASSIUM CHANNELS AND USES THEREOF

 #2
20250221967
2025-07-10

COMPOSITIONS AND METHODS FOR THE TREATMENT OF CANCER AND OTHER PROLIFERATIVE DISEASES

 #3
20220380362
2022-12-01

PYRIMIDINE COMPOUND AND MEDICAL USE THEREOF

 #4
20220281804
2022-09-08

Cyclic diones as herbicidal compounds

 #5
20220194928
2022-06-23

NOVEL N-ACYLUREA DERIVATIVE AND COMPOSITION COMPRISING SAME FOR PREVENTION OR TREATMENT OF CARDIOVASCULAR DISEASE

 #6
20200109139
2020-04-09

PYRIMIDINE COMPOUND AND MEDICAL USE THEREOF

 #7
20190119261
2019-04-25

N-acylurea derivative and composition comprising same for prevention or treatment of cardiovascular disease

 #8
20180273531
2018-09-27

PYRIMIDINE COMPOUND AND MEDICAL USE THEREOF

 #9
20180208552
2018-07-26

Urea derivative or pharmacologically acceptable salt thereof

 #10
20170209595
2017-07-27

Disulfur bridge linkers for conjugation of a cell-binding molecule

 #11
20170202975
2017-07-20

Disulfur bridge linkers for conjugation of a cell-binding molecule

 #12
20170151346
2017-06-01

Disulfur bridge linkers for conjugation of a cell-binding molecule

 #13
20150314017
2015-11-05

Disulfur bridge linkers for conjugation of a cell-binding molecule

 #14
20150183812
2015-07-02

PYRIMIDINE COMPOUND AND MEDICAL USE THEREOF

 #15
20140329818
2014-11-06

Methods of using prodrugs of methyl hydrogen fumarate and pharmaceutical compositions thereof

 #16
20120316169
2012-12-13

2-ARYL-PROPIONAMIDE DERIVATIVES USEFUL AS BRADYKININ RECEPTOR ANTAGONISTS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

 #17
20120283201
2012-11-08

9-substituted minocycline compounds

 #18
20120157523
2012-06-21

Prodrugs of methyl hydrogen fumarate, pharmaceutical compositions thereof, and methods of use

 #19
20120095003
2012-04-19

Methods of using prodrugs of methyl hydrogen fumarate and pharmaceutical compositions thereof

 #20
20120029000
2012-02-02

Process for the preparation of alogliptin

 #21
20120022257
2012-01-26

Processes for preparing HIV reverse transcriptase inhibitors

 #22
20100280124
2010-11-04

Acyl-urea derivatives and uses thereof

 #23
20100240613
2010-09-23

Pyrimidine compound and medical use thereof

 #24
20100222379
2010-09-02

Histone deacetylase inhibitors

 #25
20100048651
2010-02-25

Prodrugs of methyl hydrogen fumarate, pharmaceutical compositions thereof, and methods of use

 #26
20090325908
2009-12-31

9-substituted minocycline compounds

 #27
20080312228
2008-12-18

PYRIMIDINE COMPOUND AND MEDICAL USE THEREOF

 #28
20080188654
2008-08-07

Compounds for treatment of inflammation, diabetes and related disorders

 #29
20080103302
2008-05-01

Compounds for treatment of inflammation, diabetes and related disorders

 #30
20080085937
2008-04-10

N-(2-hydroxyalkanoyl)-N,Nā€²-dialkylureas and a process for their preparation

 #31
20070259961
2007-11-08

Compounds for treatment of inflammation, diabetes and related disorders

 #32
20070249630
2007-10-25

Phenethanolamine derivatives for treatment of respiratory diseases

 #33
20070203207
2007-08-30

Heteroaromatic glucokinase activators

 #34
20060178429
2006-08-10

Substituted-cycloalkyl and oxygenated-cycloalkyl glucokinase activators

 #35
20060014768
2006-01-19

Pyrimidine compound and medical use thereof

 #36
20050261503
2005-11-24

Heteroaromatic glucokinase activators

 #37
20050209338
2005-09-22

Phenethanolamine derivatives for treatment of respiratory diseases